Instrument Inactif

Autres langues GW PHARMACEUTICALS OTC Markets

Actions

GWPRF

GB0030544687

Recherche biotechnologique et médicale

Autres langues

06/04/23	Fitch Affirms Jazz's IDR at 'BB-'; Outlook Positive
23/01/23	Former President of GW Pharmaceuticals USA Joins Lexaria Bioscience as Strategic Advisor
28/03/22	Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing
02/03/22	JAZZ PHARMACEUTICALS ANNOUNCES FULL YEAR AND FOURTH QUARTER 2021 FINANCIAL RESULTS
12/08/21	Jazz Pharmaceuticals : U.S. FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav
10/08/21	Jazz Pharmaceuticals' : Subsidiary Gets UK Approval for Epidyolex in Patients With Tuberous Sclerosis Complex-Related Seizures
10/08/21	Jazz Pharmaceuticals : GW Pharmaceuticals Bags UK Nod for New Use of Cannabis-Based Seizure Drug
10/08/21	Gw Pharmaceuticals Receives Approval for Epidyolex (Cannabidiol) from the MHRA for the Treatment of Seizures Associated with Tuberous Sclerosis Complex
06/07/21	HINTERGRUND/Bei Pharma-Übernahmen schlagen inzwischen oft Midcaps zu
17/06/21	Jazz Pharmaceuticals : Updates 2021 Full-Year Guidance Following GW Pharmaceuticals Buy
17/06/21	Jazz Pharmaceuticals : Updates FY2021 Outlook to Reflect GW Pharmaceuticals Purchase
26/05/21	Palla Pharma : Names New CEO; Shares Soar 18%
12/05/21	Alkame : PAO Group, Inc.'s CBD Nutraceuticals Expected To Deliver Revenue-Generating Catalyst in 2021; New Partnerships Expand Its Long-Term CBD Pharmaceutical Programs
10/05/21	GW Pharmaceuticals plc(NasdaqGM:GWPH) dropped from S&P Global BMI Index
06/05/21	PAO Group, With A CRO On Its Side, Could Deliver Its First CBD-Based Therapeutic By Year's End
05/05/21	GW PHARMACEUTICALS PLC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)
05/05/21	Jazz Pharmaceuticals : Completes Purchase of GW Pharmaceuticals
05/05/21	GW Pharmaceuticals : Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc
05/05/21	GW Pharmaceuticals plc(NasdaqGM:GWPH) dropped from NASDAQ Composite Index
05/05/21	Jazz Pharmaceuticals plc completed the acquisition of GW Pharmaceuticals plc.
04/05/21	GW Pharmaceuticals plc(NasdaqGM:GWPH) dropped from NASDAQ Biotechnology Index
03/05/21	GW PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
03/05/21	Gw Pharmaceuticals plc Reports Earnings Results for the First Quarter Ended March 31, 2021
30/04/21	Jazz Pharmaceuticals : Closes $1.5 Billion Notes Offering
29/04/21	GW Pharmaceuticals : recognised for leadership in prescription cannabis-based medicines with prestigious Queen's Award for Enterprise in Innovation